Showing 1 - 20 results of 41 for search '"TFCP2"', query time: 0.22s Refine Results
  1. 1
  2. 2

    TFCP2 Is Required for YAP-Dependent Transcription to Stimulate Liver Malignancy by Xiao Zhang, Fenyong Sun, Yongxia Qiao, Weisheng Zheng, Ya Liu, Yan Chen, Qi Wu, Xiangfan Liu, Guoqing Zhu, Yuxin Chen, Yongchun Yu, Qiuhui Pan, Jiayi Wang

    Published 2017-10-01
    “…Mechanistically, YAP function is stimulated by TFCP2 via a WW-PSY interaction. TFCP2 also maintains YAP stability by inhibiting βTrCP. …”
    Get full text
    Article
  3. 3

    Hypoxia-induced immortalization of primary cells depends on Tfcp2L1 expression by D. Otero-Albiol, J. M. Santos-Pereira, A. Lucena-Cacace, C. Clemente-González, S. Muñoz-Galvan, Y. Yoshida, A. Carnero

    Published 2024-02-01
    “…Tfcp2l1 expression is lost during culture in normoxia, and its expression in hypoxia is regulated by Hif1α. …”
    Get full text
    Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Factor quinolinone inhibitors disrupt spindles and multiple LSF (TFCP2)-protein interactions in mitosis, including with microtubule-associated proteins by Sarah A. Yunes, Jennifer L. S. Willoughby, Julian H. Kwan, Jessica M. Biagi, Niranjana Pokharel, Hang Gyeong Chin, Emily A. York, Kuan-Chung Su, Kelly George, Jagesh V. Shah, Andrew Emili, Scott E. Schaus, Ulla Hansen

    Published 2022-01-01
    “…Factor quinolinone inhibitors (FQIs), a first-in-class set of small molecule inhibitors targeted to the transcription factor LSF (TFCP2), exhibit promising cancer chemotherapeutic properties. …”
    Get full text
    Article
  12. 12

    Factor quinolinone inhibitors disrupt spindles and multiple LSF (TFCP2)-protein interactions in mitosis, including with microtubule-associated proteins. by Sarah A Yunes, Jennifer L S Willoughby, Julian H Kwan, Jessica M Biagi, Niranjana Pokharel, Hang Gyeong Chin, Emily A York, Kuan-Chung Su, Kelly George, Jagesh V Shah, Andrew Emili, Scott E Schaus, Ulla Hansen

    Published 2022-01-01
    “…Factor quinolinone inhibitors (FQIs), a first-in-class set of small molecule inhibitors targeted to the transcription factor LSF (TFCP2), exhibit promising cancer chemotherapeutic properties. …”
    Get full text
    Article
  13. 13
  14. 14

    Klf2 and Tfcp2l1, Two Wnt/β-Catenin Targets, Act Synergistically to Induce and Maintain Naive Pluripotency by Dongbo Qiu, Shoudong Ye, Bryan Ruiz, Xingliang Zhou, Dahai Liu, Qi Zhang, Qi-Long Ying

    Published 2015-09-01
    “…Conversely, downregulation of Klf2 and Tfcp2l1 impairs ESC self-renewal mediated by Wnt/β-catenin signaling. …”
    Get full text
    Article
  15. 15

    SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance by Bujamin H. Vokshi, Guillaume Davidson, Nassim Tawanaie Pour Sedehi, Alexandra Helleux, Marc Rippinger, Alexandre R. Haller, Justine Gantzer, Jonathan Thouvenin, Philippe Baltzinger, Rachida Bouarich, Valeria Manriquez, Sakina Zaidi, Priya Rao, Pavlos Msaouel, Xiaoping Su, Hervé Lang, Thibault Tricard, Véronique Lindner, Didier Surdez, Jean-Emmanuel Kurtz, Franck Bourdeaut, Nizar M. Tannir, Irwin Davidson, Gabriel G. Malouf

    Published 2023-05-01
    “…Using single-cell sequencing of human RMC, we defined transformation of thick ascending limb (TAL) cells into an epithelial-mesenchymal gradient of RMC cells associated with loss of renal epithelial transcription factors TFCP2L1, HOXB9 and MITF and gain of MYC and NFE2L2-associated oncogenic and ferroptosis resistance programs. …”
    Get full text
    Article
  16. 16
  17. 17
  18. 18

    TFCP2L1 as a potential diagnostic gene biomarker of Keloid given its association with immune cells-a study based on machine learning and RNA sequence by Jia Huang, Yiyi Gong, Jui-Ming Lin, Haowei Lu, Jun Chen, Ke Liu, Jinran Lin, Wenyu Wu, Xiaobo Zhou

    Published 2024-04-01
    “…These findings highlight the intertwined roles of TFCP2L1 and immune cell infiltration, lending to TFCP2L1’s potential as a diagnostic biomarker for keloids and highlights how TFCP2L1 might influence keloid development through immune cell populations.…”
    Get full text
    Article
  19. 19

    The genetic and epigenetic regulation of CD55 and its pathway analysis in colon cancer by Jiawei Liu, Jiawei Liu, Ning Fu, Zhenbang Yang, Ang Li, Hongjiao Wu, Ye Jin, Qinqin Song, Shanshan Ji, Hongxue Xu, Zhi Zhang, Xuemei Zhang, Xuemei Zhang

    Published 2023-01-01
    “…The mRNA and protein expression levels of TFCP2 were reduced by si-TFCP2. NF-κB mRNA was obviously reduced by NF-κB inhibitor and increased by NF-κB activator. …”
    Get full text
    Article
  20. 20

    Glucose Deficiency Elevates Acid-Sensing Ion Channel 2a Expression and Increases Seizure Susceptibility in Temporal Lobe Epilepsy by Haitao Zhang, Guodong Gao, Yu Zhang, Yang Sun, Huanfa Li, Shan Dong, Wei Ma, Bei Liu, Weiwen Wang, Hao Wu, Hua Zhang

    Published 2017-07-01
    “…Transcription factor CP2 (TFCP2) regulates ASIC2a expression. We report that suppressed TFCP2 expression and elevated ASIC2a expression were associated with glucose hypometabolism in the hippocampi of humans with epilepsy and of rat epilepsy model brains. …”
    Get full text
    Article